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The correlation and the level of agreement between the standardized agar dilution and the agar disk
diffusion methods for antimicrobial susceptibility testing of Campylobacter were investigated. A high-level
agreement between the two methods was evident for aminoglycosides and fluoroquinolones, while a low-level
agreement was observed for other antibiotics.
Campylobacter species, particularly Campylobacter jejuni,
have been recognized as an important cause of food-borne
bacterial diarrhea in humans worldwide (2). As enteric organ-
isms, Campylobacter spp. are carried in the intestinal tracts of
food animals, especially poultry, and they are often present in
food of animal origin through fecal contamination during pro-
cessing (17). Although most patients with Campylobacter in-
fections do not require antibiotic treatment, antimicrobial
therapy is necessary for patients with severe or prolonged
systemic diseases (2, 4). In this circumstance, macrolides (e.g.,
erythromycin) and fluoroquinolones (e.g., ciprofloxacin) are
considered the drugs of choice (2, 5). However, other antibi-
otics such as gentamicin, tetracycline, clindamycin, and ampi-
cillin may be listed as alternative drugs for the treatment of
systemic Campylobacter infections (5). Usually, antimicrobial
susceptibility testing prior to treatment of Campylobacter in-
fections is unnecessary; however, it may be useful, especially
with the increase of resistant Campylobacter organisms. Several
antimicrobial susceptibility testing methods, including agar di-
lution, broth microdilution, epsilometer test (E-test), and disk
diffusion test, have been used to measure antimicrobial resis-
tance in Campylobacter species (1, 9, 10, 11, 12, 13, 14, 15, 16,
18, 19, 20, 24). Recently, the agar dilution method has been
considered a standard antimicrobial susceptibility testing method
for thermophilic Campylobacter species (19, 22). Although the
agar dilution method is reliable and highly reproducible and also
provides quantitative MICs, it is a labor-intensive, time-consum-
ing, and costly test (6, 20). Alternatively, the agar diffusion test,
such as the disk diffusion method, is simple and inexpensive and
can provide reproducible results if it is conducted carefully with
appropriate standardization and quality controls (6, 25). Over the
years, several comparisons of the agreement between different
antimicrobial susceptibility testing methods for Campylobacter
species have been conducted (1, 9, 10, 11, 12, 13, 15, 16, 18, 24).
However, these studies were performed prior to the establish-
ment of a standardized antimicrobial susceptibility test for
Campylobacter. Since a standardized test is proposed for
Campylobacter (19), no information has been reported on the
agreement between the standardized agar dilution method and
the agar disk diffusion method. Hence, the aim of this study
was to determine whether the agar disk diffusion test could be
used as a reliable alternative method for antimicrobial suscep-
tibility testing of Campylobacter species.
Six hundred sixty-eight Campylobacter isolates (431 C. jejuni
and 237 Campylobacter coli), obtained from the intestinal tracts
of poultry with different histories of antibiotic exposure, were
evaluated for resistance to nine antimicrobial agents, including
ampicillin, tetracycline, gentamicin, kanamycin, clindamycin,
erythromycin, ciprofloxacin, norfloxacin, and nalidixic acid, by
both the standardized agar dilution method and the disk dif-
fusion method according to the guideline established by the
CLSI (formerly NCCLS) (22). All antimicrobial agents for the
agar dilution method were obtained from Sigma Chemical Co.,
St. Louis, MO, except ciprofloxacin (Serologicals Proteins,
Inc., Kankakee, IL), and antibiotic disks for the disk diffusion
method were obtained from Becton Dickinson and Company,
Sparks, MD. The concentrations of antimicrobial agents tested
in this study are shown in Table 1. For the agar dilution
method, after Campylobacter suspensions were adjusted to a
turbidity equivalent to a 0.5 McFarland standard, approxi-
mately 104 CFU of these suspensions was inoculated onto
Mueller-Hinton agar containing a twofold dilution series of
antibiotics and supplemented with 5% defibrinated sheep
blood using a multipoint inoculator (a Cathra replicator sys-
tem) with 1-mm pins (Oxoid, Inc., Ogdensburg, NY). For the
disk diffusion method, sterile cotton-tipped swabs were used to
transfer the inoculum onto Mueller-Hinton plates to produce
a confluent lawn of bacterial growth. After the inoculum on the
plates was dried, antibiotic disks were distributed over the
inoculated plates using a BBL Sensi-disc dispenser (BBL
Becton Dickinson Microbiology Systems, Cockeysville, MD).
These plates were then incubated at 42°C for 24 h under
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microaerobic conditions (5% O2, 10% CO2, and 85% N2). C.
jejuni ATCC 33560 was used as a quality control organism in
this study. The MIC breakpoints and the zone diameter break-
points of each antimicrobial agent were determined according
to the breakpoints used by the National Antimicrobial Resis-
tance Monitoring System (NARMS) and the CLSI-established
guideline for bacteria isolated from animals (7, 22, 23) (Table
1). To measure the correlation and the level of agreement
between the standardized agar dilution method and the agar
disk diffusion method, the scatter plot, the correlation coeffi-
cient, the percent agreement, and the kappa statistic were
calculated as previously described (8, 18).
Since there are no antimicrobial resistance breakpoints spe-
cific for Campylobacter currently available, the resistance
breakpoints of enteric bacteria in the family Enterobacteriaceae
have been used to determine antimicrobial resistance of
Campylobacter spp. (13, 18, 21). According to these resistance
breakpoints, a majority of Campylobacter isolates were classi-
fied as either susceptible or resistant to ciprofloxacin, norfloxa-
cin, nalidixic acid, gentamicin, and kanamycin by both the agar
dilution and the agar disk diffusion methods (Table 2). For
erythromycin, clindamycin, and ampicillin, a large number of
Campylobacter isolates were classified as intermediate to these
antimicrobial agents when the current NARMS resistance break-
points were used (Table 2). The agar dilution method and the
disk diffusion method agreed well in identifying aminoglycoside
and quinolone/fluoroquinolone resistance in Campylobacter. The
percent agreements between these methods for gentamicin, ka-
namycin, ciprofloxacin, norfloxacin, and nalidixic acid were
99.85%, 97.46%, 94.46%, 95.81%, and 91.02%, respectively
(Table 3). In terms of the kappa, an almost perfect agreement
(kappa 0.8) was also observed between the agar dilution and
the disk diffusion methods for aminoglycosides and quinolone/
fluoroquinolones (Table 3). In addition, the correlation coeffi-
cient and the scatter plot of the MICs and the zone diameters of
each antimicrobial agent evaluated in this study also demon-
strated a correlation between the standardized agar dilution and
the agar disk diffusion methods for aminoglycosides and quino-
lone/fluoroquinolones as well as for erythromycin, clindamycin,
and tetracycline. The correlation coefficients of kanamycin, cip-
rofloxacin, erythromycin, clindamycin, and tetracycline were
0.937, 0.86, 0.885, 0.8, and0.863, respectively, whereas
the correlation coefficient between the MICs and the zone
diameters of ampicillin was 0.588. When the numbers of
falsely susceptible and falsely resistant Campylobacter isolates
were investigated, the numbers of isolates that were classified
as resistant by the agar dilution method but susceptible by the
disk diffusion method (falsely susceptible) were less than 1.5%
of the isolates tested for resistance to every antimicrobial agent
except ampicillin and tetracycline (Table 3). Likewise, the
numbers of Campylobacter isolates that were classified as sus-
ceptible by the agar dilution method but resistant by the disk
diffusion method (falsely resistant) were less than 3% of the
isolates tested for resistance to every antimicrobial agent ex-
cept ampicillin (Table 3).
In this study, Campylobacter strains that were resistant to
fluoroquinolones and aminoglycosides by the standardized
agar dilution method were also resistant to these antimicrobial
agents by the disk diffusion method. No zones of inhibition
around these antibiotic disks were observed among the resis-
tant Campylobacter strains, while large clear zones of inhibition
averaging more than 37 mm in diameter were observed around
the disks of the susceptible Campylobacter strains. The drastic
difference in the zone of inhibition diameters, a high correla-
tion coefficient, a high percent agreement, and a high kappa
value between the standardized agar dilution and the agar disk
diffusion methods indicate that the disk diffusion test is a
reliable screening method for antimicrobial susceptibility test-
ing of thermophilic Campylobacter to quinolone/fluoroquin-
olone and aminoglycoside antibiotics. This finding is correlated
well with the previous study by Gaudreau and Gilbert, who
reported a complete agreement between the agar dilution
method and the disk diffusion method for susceptibility testing
of C. jejuni and C. coli to ciprofloxacin (12). In addition,
TABLE 1. Breakpoints of the agar dilution and disk diffusion
methods used to determine antimicrobial susceptibility of
Campylobacter isolates
Antimicrobial
agent
Result for method:
Agar dilution Disk diffusion
Test
range
(g/ml)
MIC breakpoint
(g/ml)a
Disk
concn
(g)
Zone diam
breakpoint (mm)b
S I R S I R
Ampicillin 0.06–128 8 16 32 10 17 14–16 13
Tetracycline 0.06–128 4 8 16 30 19 15–18 14
Gentamicin 0.06–128 4 8 16 10 15 13–14 12
Kanamycin 0.25–128 16 32 64 30 18 14–17 13
Clindamycin 0.06–128 0.5 1–2 4 2 21 15–20 14
Erythromycin 0.06–128 0.5 1–4 8 15 23 14–22 13
Ciprofloxacin 0.008–128 1 2 4 5 21 16–20 15
Norfloxacin 0.06–128 4 8 16 10 17 13–16 12
Nalidixic acid 0.25–128 16 32 30 19 14–18 13
a MIC breakpoints for enteric bacteria from the NARMS were used for all
antimicrobial agents except norfloxacin. MIC breakpoints for Enterobacteriaceae
for norfloxacin were recommended by the CLSI (formerly NCCLS). S, suscep-
tible; I, intermediate; R, resistant.
b Zone diameter breakpoints of ampicillin, tetracycline, gentamicin, kanamy-
cin, clindamycin, and erythromycin for bacteria isolated from animals were
recommended by the CLSI. Zone diameter breakpoints of ciprofloxacin, nor-
floxacin, and nalidixic acid for Enterobacteriaceae were recommended by the
CLSI. S, susceptible; I, intermediate; R, resistant.
TABLE 2. Antimicrobial susceptibility patterns of Campylobacter spp.
identified by the agar dilution and the disk diffusion methodsa
Antimicrobial
agent
Agar dilution method Disk diffusion method
No. of
Campylobacter
isolatesb
% of
resistant
isolates
No. of
Campylobacter
isolatesb
% of
resistant
isolates
S I R S I R
Ampicillin 434 154 75 11.31 416 138 109 16.44
Tetracycline 158 4 505 75.71 195 49 423 63.42
Gentamicin 668 0 0 0 667 0 1 0.15
Kanamycin 418 2 248 37.13 415 10 243 36.38
Clindamycin 159 366 143 21.41 329 178 161 24.10
Erythromycin 76 413 179 26.80 449 62 157 23.50
Ciprofloxacin 444 10 214 32.04 437 2 229 34.28
Norfloxacin 451 4 213 31.89 439 0 229 34.28
Nalidixic acid 454 0 214 32.04 434 31 203 30.39
a The total number of Campylobacter isolates tested for antimicrobial resis-
tance was 668 for all antimicrobials except ampicillin (663 isolates) and tetracy-
cline (667 isolates).
b Number of susceptible (S), intermediate (I), and resistant (R) Campylobacter
isolates identified by the agar dilution method or by the disk diffusion method.
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Frediani-Wolf and Stephan also suggested that the disk diffu-
sion method can be used as a reliable and easy tool for mon-
itoring the prevalence of ciprofloxacin-resistant C. jejuni
strains, although they found a weak correlation between the
MIC and zone diameter results for ciprofloxacin-susceptible
strains (11).
When the current NARMS resistance breakpoints were
used, a large number of Campylobacter isolates were classified
as intermediate to erythromycin and clindamycin by the agar
dilution method. Since the MICs of erythromycin for C. jejuni
ATCC 33560, the quality control organism, and the majority of
Campylobacter isolates tested in this study fell consistently in a
range between 1 and 4 g/ml, this information, plus the find-
ings from other studies (3, 12, 14, 16), warrants a change of the
FIG. 1. Scatter plot of the MICs in the agar dilution method and the zone diameters in the disk diffusion method with tentative breakpoints
(dashed line) for ciprofloxacin (I), erythromycin (II), clindamycin (III), and tetracycline (IV) against Campylobacter species. A, the area where
Campylobacter isolates were susceptible to the antimicrobial agent by both the agar dilution and the disk diffusion methods. B, the area where
Campylobacter isolates were resistant to the antimicrobial agent by both the agar dilution and the disk diffusion methods. The values of 4, 3,
2, 1, 0, 1, 2, 3, 4, 5, 6, and 7 on the x axis represents the log2 MIC of each MIC, which are equivalent to 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8, 16,
32, 64, and 128 /ml, respectively.
TABLE 3. Agreement between the agar dilution and disk diffusion methods for antimicrobial susceptibility testing of Campylobacter speciesa
Antimicrobial
agent
No. of Campylobacter isolates
Total no. of isolates
tested by both
AD and DD
Total no. of isolates
with agreement of
results for both
AD and DD
%
agreement
between AD
and DD
KappabSusceptible by
both AD
and DD
Susceptible by AD
but resistant
by DD
Susceptible by DD
but resistant
by AD
Resistant by
both AD
and DD
Ampicillin 336 39 14 45 663 444 66.97 0.37
Tetracycline 143 14 50 408 667 552 82.76 0.62
Gentamicin 667 1 0 0 668 667 99.85 NAc
Kanamycin 408 1 6 243 668 651 97.46 0.95
Clindamycin 127 0 7 129 668 397 59.43 0.41
Erythromycin 74 0 9 150 668 264 39.52 0.25
Ciprofloxacin 422 20 5 209 668 631 94.46 0.88
Norfloxacin 431 20 4 209 668 640 95.81 0.91
Nalidixic acid 425 20 9 183 668 608 91.02 0.81
a AD, agar dilution; DD, disk diffusion.
b The magnitude of kappa indicates the level of agreement between the two tests as follows: 0.2, slight agreement; 0.2 to 0.4, fair agreement; 0.4 to 0.6, moderate
agreement; 0.6 to 0.8, substantial agreement; 0.8, almost perfect agreement.
c The kappa value for gentamicin could not be calculated because none of the isolates was classified as resistant to this antibiotic by both methods.
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MIC breakpoints of erythromycin for susceptible Campy-
lobacter isolates. Our data suggest that the breakpoint for
erythromycin-susceptible Campylobacter strains may be more
appropriately set at 2 g/ml instead of 0.5 g/ml. If the
MIC breakpoints of erythromycin for thermophilic Campy-
lobacter are changed to 2 g/ml for susceptible isolates and
8 g/ml for resistant isolates and the zone diameter break-
points of the disk diffusion method are set at 23 mm for
susceptible isolates and 18 mm for resistant isolates (Fig. 1),
the percent agreement as well as the kappa value between the
agar dilution method and the disk diffusion method for eryth-
romycin would significantly improve, while the numbers of
falsely susceptible and falsely resistant isolates would still be
less than 1.5% and 3%, respectively. Likewise, if the MIC
breakpoints for clindamycin are changed to 2 g/ml for sus-
ceptible isolates and 8 g/ml for resistant isolates and the
zone diameter breakpoints are changed to 17 mm for sus-
ceptible isolates and 12 mm for resistant isolates (Fig. 1), the
percent agreement and the kappa value between the agar di-
lution and the disk diffusion methods for clindamycin would
increase dramatically. Also, the numbers of falsely susceptible
and falsely resistant Campylobacter isolates would still be in an
acceptable range.
Some Campylobacter isolates that were determined to be
tetracycline resistant by the agar dilution method were classi-
fied as susceptible or intermediate by the disk diffusion
method. This may explain why the percent agreement and the
kappa between the agar dilution method and the disk diffusion
method for tetracycline were not as high as those of the quin-
olone/fluoroquinolones and aminoglycosides. Although the
kappa value for tetracycline demonstrated moderate agreement
(kappa  0.62) between the two methods, the correlation coeffi-
cient revealed a strong correlation (r0.863) between the agar
dilution and disk diffusion methods. Likewise, Alfredson et al.
also reported that the disk diffusion method correlated well
with the agar dilution method when they were used for the
screening of tetracycline-resistant Campylobacter strains (1).
Although the current breakpoints used for tetracycline for
enteric bacteria belonging to the family Enterobacteriaceae may
be used for Campylobacter spp., it will be better if the zone
diameter breakpoints are modified to 28 mm for susceptible
strains and 18 mm for resistant strains (Fig. 1). These new
zone diameter breakpoints for tetracycline will help reduce the
numbers of falsely susceptible Campylobacter strains by the
agar disk diffusion test from 50 isolates to 16 isolates while
increasing the percent agreement between the agar dilution
method and the disk diffusion method to 89.51%.
In this study, a weak agreement (kappa  0.37) and a weak
correlation (r  0.58) between the agar dilution and the disk
diffusion methods was observed for ampicillin. Similar to our
finding, Gaudreau and Gilbert also reported that the correla-
tion coefficient between the two methods for ampicillin was
only 0.57 (12). Since the scatter plot of the MICs and the zone
diameters for ampicillin were widely distributed in this study
and because the correlation between the two methods was
quite poor, the tentative breakpoints of ampicillin for thermo-
philic Campylobacter cannot be provided by this study.
Although the disk diffusion method is not as complicated to
perform as the agar dilution method and provides reliable
results for several classes of antimicrobials, only qualitative
data can be obtained from this method. Moreover, the poor
growth of Campylobacter isolates on the plates, which was
observed sometimes with the disk diffusion method, can also
cause difficulty in interpreting the antimicrobial resistance re-
sults. Nevertheless, this method is very useful, especially when
several antimicrobial agents need to be tested against a few
isolates. If the quantitative data are required, other methods,
such as the agar dilution method or the E-test, should be used.
In conclusion, this study reveals a high-level correlation be-
tween the standardized agar dilution method and the agar disk
diffusion method for aminoglycosides, quinolone/fluoroquino-
lones, erythromycin, clindamycin, and tetracycline in evaluat-
ing the resistance of Campylobacter spp. to these antimicrobial
agents. This study also suggests that the disk diffusion method
can be used as a reliable alternative method for susceptibility
testing of thermophilic Campylobacter to several classes of
antimicrobial agents, particularly to quinolone/fluoroquinolo-
nes and aminoglycosides. Based on the data obtained in this
study, we proposed some changes for the breakpoints of eryth-
romycin, clindamycin, and tetracycline. However, until the
standard breakpoints specific for Campylobacter are estab-
lished and validated, the agar dilution method is likely to be a
preferable method for determining antimicrobial resistance of
Campylobacter species.
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